Skip to main content
    I

    Iovance Biotherapeutics Inc (IOVA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.55
    -0.21 (-2.71%)

    Market Cap: $3.59B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Iovance Biotherapeutics Inc (IOVA) Government Contracts

    Updated Oct 12, 2026. Contract data from federal award records.

    Federal agencies obligated $0 to Iovance Biotherapeutics over the 12 months through Sep 30, 2026. Iovance Biotherapeutics had obligation activity on 1 federal contract over the same 12 months, all of them new. Agencies report contract actions with a delay, so the latest months, Jul to Sep 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.

    Federal Obligations

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated.

    Obligations
    $0
    Obligations to revenue
    0.0%
    Prior 12 months$0
    Contracts with activity1
    New contracts1

    12 months through Sep 30, 2026

    Largest New Awards

    Award IDAgencyAmountStartEndDescription
    36C24826N0268Department of Veterans Affairs$0Jan 5, 2026Apr 4, 2026AMTAGVI
    New federal contracts awarded in the 12 months through Sep 30, 2026, largest first. All from the Department of Veterans Affairs.

    Monthly Obligations

    The latest complete month, Jun 2026, had no net obligations. The largest month in the table was Jan 2026, at $393,366.

    MonthObligations
    Sep 2026$0
    Aug 2026$0
    Jul 2026$0
    Jun 2026$0
    May 2026$0
    Apr 2026-$393,366
    Mar 2026$0
    Feb 2026$0
    Jan 2026$393,366
    Dec 2025$0
    Nov 2025$0
    Oct 2025$0
    MonthObligations
    Sep 2025$0
    Aug 2025$0
    Jul 2025-$219,576
    Jun 2025$0
    May 2025$0
    Apr 2025$219,576
    Mar 2025$0
    Feb 2025$0
    Jan 2025$0
    Dec 2024$0
    Nov 2024$0
    Oct 2024$0

    Net obligations recorded each month, newest first. Agencies report contract actions with a delay (the Defense Department about 90 days), so the latest months, Jul to Sep 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.

    Frequently Asked Questions About IOVA

    How much does Iovance Biotherapeutics receive in federal contracts?

    Iovance Biotherapeutics had $0 in federal contract obligations over the 12 months through Sep 30, 2026, compared with $0 in the 12 months before. Obligations are contract bookings by the awarding agency, not recognized revenue.

    What are Iovance Biotherapeutics' largest government contracts?

    The largest new awards over the 12 months through Sep 30, 2026 were 36C24826N0268, Department of Veterans Affairs, $0, started Jan 5, 2026.

    What new federal contracts did Iovance Biotherapeutics win in the 12 months through Sep 30, 2026?

    Iovance Biotherapeutics won 1 new federal contract in the 12 months through Sep 30, 2026. The largest was 36C24826N0268, Department of Veterans Affairs, $0, started Jan 5, 2026.

    How do Iovance Biotherapeutics' federal obligations compare with its revenue?

    Federal contract obligations were $0 over the 12 months through Sep 30, 2026, equivalent to less than 1% of Iovance Biotherapeutics' revenue. Obligations are amounts the government committed to contracts in the period, not the share of Iovance Biotherapeutics' revenue that comes from the government.